title: Aquaporin-2 is a potential biomarker for tolvaptan efficacy in decompensated heart failure complicated by diabetic nephrotic syndrome.
authors.affiliation: Department of Cardiovascular Medicine, Saga University, 5-1-1, Nabeshima, Saga 849-8501, Japan.
authors.forename: Atsushi
authors.initials: A
authors.lastname: Tanaka
authors.affiliation: Division of Nephrology, Department of Internal Medicine, Shinmatsudo Central General Hospital, 1-380, Shinmatsudo, Matsudo 270-0034, Japan.
authors.forename: Tsukasa
authors.initials: T
authors.lastname: Nakamura
authors.affiliation: Division of Nephrology, Department of Internal Medicine, Shinmatsudo Central General Hospital, 1-380, Shinmatsudo, Matsudo 270-0034, Japan.
authors.forename: Eiichi
authors.initials: E
authors.lastname: Sato
authors.affiliation: Department of Cardiovascular Medicine, Saga University, 5-1-1, Nabeshima, Saga 849-8501, Japan. Electronic address: node@cc.saga-u.ac.jp.
authors.forename: Koichi
authors.initials: K
authors.lastname: Node
mesh_terms: D000368:Aged; D065092:Antidiuretic Hormone Receptor Antagonists / Q000627:therapeutic use*; D051399:Aquaporin 2 / Q000652:urine*; D001552:Benzazepines / Q000627:therapeutic use*; D015415:Biomarkers / Q000652:urine; D003928:Diabetic Nephropathies / Q000150:complications / Q000188:drug therapy / Q000652:urine*; D005260:Female; D006333:Heart Failure / Q000150:complications / Q000188:drug therapy / Q000652:urine*; D006801:Humans; D009404:Nephrotic Syndrome / Q000150:complications / Q000188:drug therapy / Q000652:urine*; D000077602:Tolvaptan; D016896:Treatment Outcome
chemical_list: C496023:AQP2 protein, human; D065092:Antidiuretic Hormone Receptor Antagonists; D051399:Aquaporin 2; D001552:Benzazepines; D015415:Biomarkers; D000077602:Tolvaptan
keywords: Aquaporin-2; Diabetic nephropathy; Heart failure; Tolvaptan